Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 22995777)

1.

Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.

Yeh HH, Tian M, Hinz R, Young D, Shavrin A, Mukhapadhyay U, Flores LG, Balatoni J, Soghomonyan S, Jeong HJ, Pal A, Uthamanthil R, Jackson JN, Nishii R, Mizuma H, Onoe H, Kagawa S, Higashi T, Fukumitsu N, Alauddin M, Tong W, Herholz K, Gelovani JG.

Neuroimage. 2013 Jan 1;64:630-9. doi: 10.1016/j.neuroimage.2012.09.019. Epub 2012 Sep 17.

2.

Kinetic Analysis and Quantification of [(11)C]Martinostat for in Vivo HDAC Imaging of the Brain.

Wey HY, Wang C, Schroeder FA, Logan J, Price JC, Hooker JM.

ACS Chem Neurosci. 2015 May 20;6(5):708-15. doi: 10.1021/acschemneuro.5b00066. Epub 2015 Mar 25.

PMID:
25768025
3.

In vivo imaging of histone deacetylases (HDACs) in the central nervous system and major peripheral organs.

Wang C, Schroeder FA, Wey HY, Borra R, Wagner FF, Reis S, Kim SW, Holson EB, Haggarty SJ, Hooker JM.

J Med Chem. 2014 Oct 9;57(19):7999-8009. doi: 10.1021/jm500872p. Epub 2014 Sep 18.

PMID:
25203558
4.

PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.

Schroeder FA, Wang C, Van de Bittner GC, Neelamegam R, Takakura WR, Karunakaran A, Wey HY, Reis SA, Gale J, Zhang YL, Holson EB, Haggarty SJ, Hooker JM.

ACS Chem Neurosci. 2014 Oct 15;5(10):1055-62. doi: 10.1021/cn500162j. Epub 2014 Sep 19.

PMID:
25188794
5.

Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model.

Tang W, Kuruvilla SA, Galitovskiy V, Pan ML, Grando SA, Mukherjee J.

Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):324-32. eCollection 2014.

6.

Design, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain.

Wang C, Eessalu TE, Barth VN, Mitch CH, Wagner FF, Hong Y, Neelamegam R, Schroeder FA, Holson EB, Haggarty SJ, Hooker JM.

Am J Nucl Med Mol Imaging. 2013 Dec 15;4(1):29-38. eCollection 2013.

7.

Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.

Seo YJ, Muench L, Reid A, Chen J, Kang Y, Hooker JM, Volkow ND, Fowler JS, Kim SW.

Bioorg Med Chem Lett. 2013 Dec 15;23(24):6700-5. doi: 10.1016/j.bmcl.2013.10.038. Epub 2013 Oct 30.

8.

Epigenetic mechanisms linking diabetes and synaptic impairments.

Wang J, Gong B, Zhao W, Tang C, Varghese M, Nguyen T, Bi W, Bilski A, Begum S, Vempati P, Knable L, Ho L, Pasinetti GM.

Diabetes. 2014 Feb;63(2):645-54. doi: 10.2337/db13-1063. Epub 2013 Oct 23.

9.

Visualizing epigenetics: current advances and advantages in HDAC PET imaging techniques.

Wang C, Schroeder FA, Hooker JM.

Neuroscience. 2014 Apr 4;264:186-97. doi: 10.1016/j.neuroscience.2013.09.018. Epub 2013 Sep 17. Review.

10.

Class I HDAC imaging using [ (3)H]CI-994 autoradiography.

Wang Y, Zhang YL, Hennig K, Gale JP, Hong Y, Cha A, Riley M, Wagner F, Haggarty SJ, Holson E, Hooker J.

Epigenetics. 2013 Jul;8(7):756-64. doi: 10.4161/epi.25202. Epub 2013 Jun 11.

11.

Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.

Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, Haass C, Bartenstein P.

J Nucl Med. 2013 Jul;54(7):1127-34. doi: 10.2967/jnumed.112.114660. Epub 2013 May 31.

12.

Assessment of the 18F-labeled PET tracer LMI1195 for imaging norepinephrine handling in rat hearts.

Higuchi T, Yousefi BH, Kaiser F, Gärtner F, Rischpler C, Reder S, Yu M, Robinson S, Schwaiger M, Nekolla SG.

J Nucl Med. 2013 Jul;54(7):1142-6. doi: 10.2967/jnumed.112.104232. Epub 2013 May 13.

13.

Simultaneous 18F choline positron emission tomography/magnetic resonance imaging of the prostate: initial results.

Wetter A, Lipponer C, Nensa F, Beiderwellen K, Olbricht T, Rübben H, Bockisch A, Schlosser T, Heusner TA, Lauenstein TC.

Invest Radiol. 2013 May;48(5):256-62. doi: 10.1097/RLI.0b013e318282c654.

PMID:
23462678
14.

Magnetic resonance-based attenuation correction for PET/MR hybrid imaging using continuous valued attenuation maps.

Navalpakkam BK, Braun H, Kuwert T, Quick HH.

Invest Radiol. 2013 May;48(5):323-32. doi: 10.1097/RLI.0b013e318283292f.

PMID:
23442772
15.

Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.

Kim M, Higuchi T, Arisaka Y, Achmad A, Tokue A, Tominaga H, Miyashita G, Miyazaki H, Negishi A, Yokoo S, Tsushima Y.

Ann Nucl Med. 2013 Jun;27(5):423-30. doi: 10.1007/s12149-013-0701-0. Epub 2013 Feb 24.

PMID:
23436243
16.

Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.

Hartung-Knemeyer V, Beiderwellen KJ, Buchbender C, Kuehl H, Lauenstein TC, Bockisch A, Poeppel TD.

Invest Radiol. 2013 May;48(5):290-4. doi: 10.1097/RLI.0b013e3182823695.

PMID:
23399811
17.

Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.

Ohshima Y, Hanaoka H, Tominaga H, Kanai Y, Kaira K, Yamaguchi A, Nagamori S, Oriuchi N, Tsushima Y, Endo K, Ishioka NS.

Ann Nucl Med. 2013 May;27(4):314-24. doi: 10.1007/s12149-013-0687-7. Epub 2013 Jan 23.

PMID:
23337966
18.

Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.

Hostetler ED, Sanabria-Bohórquez S, Eng W, Joshi AD, Patel S, Gibson RE, O'Malley S, Krause SM, Ryan C, Riffel K, Bi S, Okamoto O, Kawamoto H, Ozaki S, Ohta H, de Groot T, Bormans G, Depré M, de Hoon J, De Lepeleire I, Reynders T, Cook JJ, Burns HD, Egan M, Cho W, van Laere K, Hargreaves RJ.

Neuroimage. 2013 Mar;68:1-10. doi: 10.1016/j.neuroimage.2012.11.053. Epub 2012 Dec 11.

PMID:
23238431
19.

Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 1.

20.

Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk